Stemline Therapeutics, Inc. (STML) CEO Ivan Bergstein on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/04/19
Stemline Therapeutics (STML) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/02/19
Wedbush: Trajectory For Stemline Therapeutics' Blood Cancer Drug Priced Into StockBenzinga • 05/13/19
Stemline Therapeutics' (STML) CEO Ivan Bergstein on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/11/19
Stemline Therapeutics (STML) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/10/19